Skip to main content

IDWeek 2024 Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

Back

Naoki Ishibashi, MD

Pharmaceutical Research Division, Japan

Disclosure(s): SHIONOGI & CO., LTD.: Employee

Poster(s):

(P-1110) The Impact of Xeruborbactam on in vitro Activity of Cefiderocol against a Panel of Enterobacterales Enriched with Isolates with Reduced Cefiderocol Susceptibility

Friday, October 18, 2024
12:15 PM – 1:30 PM US PT